NCT07283731 2026-04-06
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
M.D. Anderson Cancer Center
Phase 2 Suspended
Clinical Trials
8 trialsNCT05000294 2026-02-18
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
Phase 1/2 Suspended
NCT03316573 2026-02-10
Pembrolizumab in Neoplasms or Lymphomas
Dana-Farber Cancer Institute
Phase 2 Suspended
NCT06806228 2025-11-19
Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)
Petrov, Andrey
Phase 1 Suspended
NCT04824352 2024-05-14
AIEO
Peking University People's Hospital
Phase 2 Suspended
NCT02924714 2022-02-18
SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST
Oslo University Hospital
Phase NA Suspended
NCT02008019 2017-08-07
CHONRAD
Centre Leon Berard
Phase 2 Suspended
NCT01921998 2015-02-04
BioACT
The Christie NHS Foundation Trust
Suspended